XML 70 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
May 01, 2020
Accounting Policies [Line Items]          
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net   $ (20,728) $ 20,564 $ 23,494  
Foreign Currency Transaction Gain (Loss), Realized   8,523 2,309 2,506  
Other Nonoperating Gains (Losses)   370 1 476  
Total other (expense) income, net   $ (11,835) 22,874 $ 26,476  
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments $ 7,211   $ 3,484    
Weighted average shares outstanding — basic   25,996,572 27,180,744 30,786,349  
Weighted average shares outstanding — diluted   25,996,572 27,773,286 31,662,705  
Weighted average anti-dilutive shares excluded from diluted net (loss) income per share attributable to Cimpress plc (1)   494,329 1,325 0  
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements   0 592,542 876,356  
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 60 $ 60     $ 60
Income tax expense (benefit)   $ 18,903 $ (80,992) $ 33,432  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 537 537 86    
Bank Overdrafts     3,768    
Advertising Expense   333,665 302,449 427,673  
Research and Development Expense   49,254 49,201 40,976  
Marketable Securities 202,961 202,961      
Unrealized Gain (Loss) on Investments   (175)      
Investments, Fair Value Disclosure 202,786 202,786      
Marketable securities 152,248 152,248 0    
Marketable securities, non-current 50,713 50,713 0    
Capitalized Computer Software, Amortization   47,560 40,753 35,068  
Capitalized Computer Software, Accumulated Amortization 231,482 231,482 180,993    
Share-based compensation expense   37,034 34,874 21,716  
Commercial Paper          
Accounting Policies [Line Items]          
Marketable Securities 74,463 74,463      
Unrealized Gain (Loss) on Investments   (28)      
Investments, Fair Value Disclosure 74,435 74,435      
Corporate Debt Securities          
Accounting Policies [Line Items]          
Marketable Securities 128,498 128,498      
Unrealized Gain (Loss) on Investments   (147)      
Investments, Fair Value Disclosure 128,351 128,351      
General and administrative expense          
Accounting Policies [Line Items]          
Share-based compensation expense   20,637 $ 21,061 12,882  
Marketable securities, current [Member]          
Accounting Policies [Line Items]          
Investments, Fair Value Disclosure 152,163 152,163      
Marketable securities, noncurrent [Member]          
Accounting Policies [Line Items]          
Investments, Fair Value Disclosure $ 50,623 $ 50,623      
Warrant [Member]          
Accounting Policies [Line Items]          
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements   368,933 73,719    
Foreign Exchange Forward [Member]          
Accounting Policies [Line Items]          
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net   $ (24,235) $ 20,882 24,215  
Interest Rate Swap [Member]          
Accounting Policies [Line Items]          
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net   3,507 $ (318) $ (721)  
Gain (Loss) on Interest Rate Derivative Instruments Not Designated as Hedging Instruments   $ 3,422